Thrive Capital Management (Pennsylvania)’s Abbott ABT Stock Holding History

Thrive Capital Management (Pennsylvania)’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-32,859	Closed	-$3.37M	–	171
2026 Q1	$3.37M	Buy	32,859 +3,923	+14%	+$443K	0.74%	65
2025 Q4	$3.63M	Buy	28,936 +10,612	+58%	+$1.35M	0.81%	56
2025 Q3	$2.45M	Buy	18,324 +3,614	+25%	+$474K	0.63%	66
2025 Q2	$2M	Buy	+14,710	New	+$1.94M	0.63%	67
2024 Q1	–	Sell	-1,966	Closed	-$216K	–	121
2023 Q4	$216K	Buy	+1,966	New	+$196K	0.12%	141
2022 Q1	–	Sell	-1,764	Closed	-$248K	–	98
2021 Q4	$248K	Sell	1,764 -2,850	-62%	-$365K	0.16%	90
2021 Q3	$545K	Buy	4,614 +156	+3%	+$19.2K	0.4%	62
2021 Q2	$517K	Buy	4,458 +1,807	+68%	+$211K	0.4%	76
2021 Q1	$318K	Buy	+2,651	New	+$314K	0.3%	84

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Thrive Capital Management (Pennsylvania)'s ABT Position: Q2 2026 in Review

Thrive Capital Management (Pennsylvania) sold out of Abbott (ABT) in Q2 2026, closing a stake of 32,859 shares — an estimated $3.37M sold.

Thrive Capital Management (Pennsylvania) first reported a position in ABT in Q1 2021 and held it in 9 quarters. The position peaked at $3.63M in Q4 2025. 2,972 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

Thrive Capital Management (Pennsylvania) reported no remaining Abbott position as of Q2 2026 after selling out during the quarter.
Thrive Capital Management (Pennsylvania) sold 32,859 Abbott shares in Q2 2026, an estimated $3.37M.
Thrive Capital Management (Pennsylvania) first reported a position in Abbott in Q1 2021 and held it in 9 quarters.
Thrive Capital Management (Pennsylvania)'s Abbott position peaked at $3.63M in Q4 2025.
2,972 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q2 2026, filed 5 Aug 2026.